Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Slide: 37 of 39

Adjunctive Proximal Balloon Embolic Protection Devices Versus PCI Alone in Patients With STEMI: All Outcomes and Adverse Events

In RCTs, the use of proximal balloon embolic protection devices did not significantly impact mortality, MI, stroke, or MACE versus a control when using the longest duration of followup. In RCTs, the use of proximal balloon embolic protection devices did not significantly impact ST-segment resolution, MBG-3, TIMI-3 blood flow, distal embolization, or ejection fraction versus a control with no data on the other intermediate health outcomes. No studies or trials evaluated the use of proximal balloon embolic protection devices in patients with mixed ACS. In one RCT, the use of a proximal balloon embolic protection device versus a control significantly prolonged procedure time. No other trials or studies evaluated the impact of proximal balloon embolic protection devices versus a control on adverse events of interest.